Skip to main content

Table 2 Results for system suitability

From: Development and validation of stability-indicating RP-HPLC method for estimation of dalfampridine in bulk drug and tablet dosage form

Sr. no. Parameters Results Acceptance criteria
1 Peak area (6 replicate injections) Area  
1 5325966
2 5351414
3 5329388
4 5320723
5 5303219
6 5336522
Mean peak area 5327872
RSD, relative standard deviation 0.3% RSD must be less than 2
2 Retention time 4.5 min Must be more than 2 min